曲妥珠单抗诱导的心脏功能障碍。 - Suppr

Suppr

超能文献

Trastuzumab-induced cardiac dysfunction.

作者信息

Panjrath Gurusher Singh, Jain Diwakar

出版信息

Nucl Med Commun. 2007 Feb;28(2):69-73. doi: 10.1097/MNM.0b013e328025ae04.

DOI:10.1097/MNM.0b013e328025ae04

PMID:17198344

Abstract

摘要

相似文献

Trastuzumab-induced cardiac dysfunction.曲妥珠单抗诱导的心脏功能障碍。

Nucl Med Commun. 2007 Feb;28(2):69-73. doi: 10.1097/MNM.0b013e328025ae04.

Trastuzumab cardiac side effects: only time will tell.曲妥珠单抗的心脏副作用：只有时间能给出答案。

J Clin Oncol. 2005 Nov 1;23(31):7775-6. doi: 10.1200/JCO.2005.04.1558.

Trastuzumab for early breast cancer.曲妥珠单抗用于早期乳腺癌。

Lancet. 2006 Jan 14;367(9505):108. doi: 10.1016/S0140-6736(06)67953-1.

Management of trastuzumab-related cardiac dysfunction.曲妥珠单抗相关性心脏功能障碍的管理。

Prog Cardiovasc Dis. 2010 Sep-Oct;53(2):130-9. doi: 10.1016/j.pcad.2010.07.001.

J Clin Oncol. 2007 Aug 10;25(23):3525-33. doi: 10.1200/JCO.2007.11.0106.

Cardiotoxicity of trastuzumab in clinical practice.曲妥珠单抗在临床实践中的心脏毒性

N Engl J Med. 2007 Jul 5;357(1):94-5. doi: 10.1056/NEJMc070065.

Troponin I as a predictor for trastuzumab-related cardiotoxicity: current data do not provide mechanistic insights or allow for incorporation into clinical practice.

J Clin Oncol. 2011 Mar 1;29(7):e175-6. doi: 10.1200/JCO.2010.32.7353. Epub 2010 Dec 28.

On the recovery of trastuzumab-related cardiac dysfunction.

Clin Oncol (R Coll Radiol). 2001;13(2):146.

Trastuzumab and breast cancer.

N Engl J Med. 2001 Sep 27;345(13):996.

Heart of darkness: the downside of trastuzumab.黑暗之心：曲妥珠单抗的弊端

J Clin Oncol. 2006 Sep 1;24(25):4056-8. doi: 10.1200/JCO.2006.07.5143. Epub 2006 Aug 14.

引用本文的文献

MRI of Cardiotoxicity.MRI 检查的心脏毒性评估。

Cardiol Clin. 2019 Nov;37(4):429-439. doi: 10.1016/j.ccl.2019.07.007. Epub 2019 Aug 31.

Nuclear cardio-oncology: From its foundation to its future.核心血管肿瘤学：从其基础到未来。

J Nucl Cardiol. 2020 Apr;27(2):511-518. doi: 10.1007/s12350-019-01655-6. Epub 2019 Feb 20.

Cardiovascular Magnetic Resonance in the Oncology Patient.肿瘤患者的心血管磁共振成像。

JACC Cardiovasc Imaging. 2018 Aug;11(8):1150-1172. doi: 10.1016/j.jcmg.2018.06.004.

Cardiotoxicity of cancer chemotherapy: identification, prevention and treatment.癌症化疗的心脏毒性：识别、预防与治疗

Ann Transl Med. 2017 Sep;5(17):348. doi: 10.21037/atm.2017.06.35.

Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions.癌症治疗的心脏并发症：病理生理学、识别、预防、治疗及未来方向

Curr Cardiol Rep. 2017 May;19(5):36. doi: 10.1007/s11886-017-0846-x.

Cardio-oncology: the Nuclear Option.心脏肿瘤学：核心选择。

Curr Cardiol Rep. 2017 Apr;19(4):31. doi: 10.1007/s11886-017-0844-z.

Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).多学科团队干预心血管肿瘤学研究（TITAN）的原理与设计

BMC Cancer. 2016 Sep 15;16(1):733. doi: 10.1186/s12885-016-2761-8.

The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy.多模态成像在癌症及癌症治疗心脏并发症管理中的作用及临床疗效。

J Nucl Cardiol. 2016 Aug;23(4):856-84. doi: 10.1007/s12350-016-0538-8. Epub 2016 Jun 1.

Can serial changes of diastolic dysfunction signal incremental risk of chemotherapy-induced heart failure missed by the timing of declining LV ejection fraction?舒张功能障碍的系列变化能否预示化疗引起的心力衰竭的渐进风险，而这种风险会被左心室射血分数下降的时间所遗漏？

J Nucl Cardiol. 2016 Aug;23(4):833-6. doi: 10.1007/s12350-015-0194-4. Epub 2015 Jul 24.

Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively.传统和新型方法评估和预防化疗相关心功能障碍的无创性评估。

J Nucl Cardiol. 2013 Jun;20(3):443-64. doi: 10.1007/s12350-013-9707-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验